Table 1.
Rating | Designation | Action | Explanation |
---|---|---|---|
A | Unknown | No known interaction | Unknown |
B | Minor | No action needed | The interaction would have limited clinical effects. May include an increase in the frequency or severity of the side effects but generally would not require a major alteration in therapy |
C | Moderate | Monitor therapy | The interaction may result to exacerbation of the patient’s condition and/or require an alteration in therapy |
D | Major | Therapy modification | The interaction may be life threatening and/or require medical serious adverse events |
X | Contraindicated | Avoid combination | The drugs are contraindicated for concurrent use |
A and B are considered nonclinically significant drug interactions, whereas C, D, and X are considered clinically significant drug interactions